Sweden
· Delayed Price · Currency is SEK Isofol Medical AB Statistics
Total Valuation
Isofol Medical AB has a market cap or net worth of SEK 468.39 million. The enterprise value is 349.24 million.
| Market Cap | 468.39M |
| Enterprise Value | 349.24M |
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Isofol Medical AB has 161.52 million shares outstanding. The number of shares has increased by 14.35% in one year.
| Shares Outstanding | 161.52M |
| Shares Change (YoY) | +14.35% |
| Shares Change (QoQ) | -4.10% |
| Owned by Insiders (%) | 13.04% |
| Owned by Institutions (%) | 16.75% |
| Float | 140.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | -483,333.33 |
| PB Ratio | 4.60 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.07 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.81
| Current Ratio | 5.81 |
| Quick Ratio | 5.67 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -29.10% and return on invested capital (ROIC) is -20.72%.
| Return on Equity (ROE) | -29.10% |
| Return on Assets (ROA) | -17.30% |
| Return on Capital (ROIC) | -20.72% |
| Revenue Per Employee | -250 |
| Profits Per Employee | -8.67M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +367.74% in the last 52 weeks. The beta is 2.05, so Isofol Medical AB's price volatility has been higher than the market average.
| Beta (5Y) | 2.05 |
| 52-Week Price Change | +367.74% |
| 50-Day Moving Average | 2.19 |
| 200-Day Moving Average | 1.06 |
| Relative Strength Index (RSI) | 52.03 |
| Average Volume (20 Days) | 5,588,781 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Isofol Medical AB had revenue of SEK -1,000 and -34.70 million in losses. Loss per share was -0.21.
| Revenue | -1,000 |
| Gross Profit | -35.21M |
| Operating Income | -39.54M |
| Pretax Income | -34.70M |
| Net Income | -34.70M |
| EBITDA | -40.25M |
| EBIT | -39.54M |
| Loss Per Share | -0.21 |
Balance Sheet
| Cash & Cash Equivalents | 119.15M |
| Total Debt | n/a |
| Net Cash | 119.15M |
| Net Cash Per Share | 0.74 |
| Equity (Book Value) | 101.91M |
| Book Value Per Share | 0.63 |
| Working Capital | 102.54M |
Cash Flow
| Operating Cash Flow | -38.51M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 3,953,800.00% |
| Pretax Margin | 3,469,600.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Isofol Medical AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.35% |
| Shareholder Yield | -14.35% |
| Earnings Yield | -7.29% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |